“How Much to Invest in Glycemic Control of a Patient With Diabetes Mellitus Type 2? A Constant Dilemma for the Brazilian Public Health System (SUS)”. Brazilian Journal of Pharmaceutical Sciences, vol. 55, Nov. 2019, p. e17197, https://doi.org/10.1590/s2175-97902019000117197.